Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 20;24(1):27.
doi: 10.1186/s12941-025-00793-9.

Long COVID clinical evaluation, research and impact on society: a global expert consensus

Collaborators, Affiliations

Long COVID clinical evaluation, research and impact on society: a global expert consensus

Andrew G Ewing et al. Ann Clin Microbiol Antimicrob. .

Erratum in

  • Correction: Long COVID clinical evaluation, research and impact on society: a global expert consensus.
    Ewing AG, Joffe D, Blitshteyn S, Brooks AES, Wist J, Bar-Yam Y, Bilodeau S, Curtin J, Duncan R, Faghy M, Galland L, Pretorius E, Salamon S, Buonsenso D, Hastie C, Kane B, Khan MA, Lal A, Lau D, MacIntyre R, McFarland S, Munblit D, Nicholson J, Ollila HM, Putrino D, Rosario A, Tan T; Long COVID consensus expert panel (Table S1). Ewing AG, et al. Ann Clin Microbiol Antimicrob. 2025 Jul 10;24(1):41. doi: 10.1186/s12941-025-00803-w. Ann Clin Microbiol Antimicrob. 2025. PMID: 40640905 Free PMC article. No abstract available.

Abstract

Background: Long COVID is a complex, heterogeneous syndrome affecting over four hundred million people globally. There are few recommendations, and no formal training exists for medical professionals to assist with clinical evaluation and management of patients with Long COVID. More research into the pathology, cellular, and molecular mechanisms of Long COVID, and treatments is needed. The goal of this work is to disseminate essential information about Long COVID and recommendations about definition, diagnosis, treatment, research and social issues to physicians, researchers, and policy makers to address this escalating global health crisis.

Methods: A 3-round modified Delphi consensus methodology was distributed internationally to 179 healthcare professionals, researchers, and persons with lived experience of Long COVID in 28 countries. Statements were combined into specific areas: definition, diagnosis, treatment, research, and society.

Results: The survey resulted in 187 comprehensive statements reaching consensus with the strongest areas being diagnosis and clinical assessment, and general research. We establish conditions for diagnosis of different subgroups within the Long COVID umbrella. Clear consensus was reached that the impacts of COVID-19 infection on children should be a research priority, and additionally on the need to determine the effects of Long COVID on societies and economies. The consensus on COVID and Long COVID is that it affects the nervous system and other organs and is not likely to be observed with initial symptoms. We note, biomarkers are critically needed to address these issues.

Conclusions: This work forms initial guidance to address the spectrum of Long COVID as a disease and reinforces the need for translational research and large-scale treatment trials for treatment protocols.

Keywords: Definition; Diagnosis; Long COVID; Research; Societies; Treatment.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The WCG IRB reviewed and approved this study (IRB Tracking Number: 20234854). After confirming they understood the study requirements, all participants provided written consent in English via the survey platform (Online Encrypted Google Forms). Only 3 assigned persons had access to the dataset, and the Delphi study executive committee members were the final ones responsible for deciding to submit it for publication. Consent for publication: Not applicable. Competing interests: Etheresia Pretorius has filed various patents related to methods for the early detection of inflammatory disease risk. She has also filed a patent for a novel method for the diagnosis of coagulation pathology in Long COVID. All other authors state no competing of interest.

Figures

Fig. 1
Fig. 1
Breakdown of Long COVID consensus expert panel giving areas of expertise, age range, gender pattern, and countries
Fig. 2
Fig. 2
Design of the 3-stage modified Delphi survey. A total of 179 experts participated over the three stages. A total of 1574 experts from searching the literature were initially contacted and 32 gave responses to an open-ended set of questions (see Table S4). In the Delphi rounds, the response rate to the first round of 132 statements was 46% and the response rate to the second round of 105 statements was 49%
Fig. 3
Fig. 3
Summary of consensus statements by topic and consensus level (listed in Table 1)

References

    1. WHO. Number of COVID-19 cases reported to WHO: WHO COVID-19 dashboard, https://data.who.int/dashboards/covid19/cases?n=c. Last accessed April 13, 2025.
    1. Kuang S, Earl S, Clarke J, Zakaria D, Demers A. Experiences of Canadians with long-term symptoms following COVID-19. Report No. 2291–0840, 2023.
    1. Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28:2398–405. 10.1038/s41591-022-02051-3. - PMC - PubMed
    1. Dashboards NC. Dashboard: Long COVID: demographics of diagnosed long COVID patients (U09.9). https://covid.cd2h.org/dashboard/public-health/long-covid/13. Last accessed April 13, 2025.
    1. Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Brady M, Hishmeh L, Attree E, Heightman M, Banerjee R, Banerjee A, COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11: e048391. 10.1136/bmjopen-2020-048391. - PMC - PubMed

LinkOut - more resources